Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech innovator, announced its inclusion in an editorial by NetworkNewsWire titled“ ...

Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech firm developing targeted therapies for genetic medicine delivery, announced a ...

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...

Early on Thursday, the stock of Nvidia is indicating further rises. Overtaking other industry giants like Apple and Microsoft, the chipmaker became the first publicly traded business to reach the $4 ...

CLDI Stock- Calidi Biotherapeutics raises $4.6M via discounted warrants to fund clinical programs and extend operational ...

Calidi Biotherapeutics stock was up 171.84% in pre-market trading on Wednesday, following a 39.47% rally yesterday. However, ...

NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the ...

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

Calidi Biotherapeutics Inc. CLDI stock surged by 39.47% in the after-hours trading session on Tuesday. The stock price ...

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...

NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /PRNewswire/ -- An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people ...